首页> 外国专利> HUMAN MICROPHYSIOLOGICAL CELL SYSTEM FOR LIVER DISEASE CONVERSION WITH PROV 1-18585 AND PROV 2-19154

HUMAN MICROPHYSIOLOGICAL CELL SYSTEM FOR LIVER DISEASE CONVERSION WITH PROV 1-18585 AND PROV 2-19154

机译:1-18585和2-19154省份用于人类肝脏疾病转化的人类微生理细胞系统

摘要

The present invention is related to the field of liver disease. Solid substrates comprising microfluidic channels (e.g., microchips) are configured to support growing and differentiating hepatocytes and are contemplated to provide a suitable environment for the development of fully functional liver tissue. These solid substrates can be used to induce various toxicity conditions in the liver tissue subsequent to the exposure to various chemicals. For example, chronic exposure to ethanol induces a clinical state of alcoholic liver disease in the liver tissue. Alternatively, certain disease states can result in the development of non-alcoholic liver diseases (e.g., non- alcoholic steatohepatitis; NASH).
机译:本发明涉及肝脏疾病领域。包含微流体通道(例如,微芯片)的固体底物被配置为支持生长和分化的肝细胞,并被认为为全功能肝组织的发育提供合适的环境。在暴露于各种化学物质之后,这些固体底物可用于在肝组织中诱发各种毒性条件。例如,长期暴露于乙醇会在肝组织中诱发酒精性肝病的临床状态。可选地,某些疾病状态可导致非酒精性肝病的发展(例如,非酒精性脂肪性肝炎; NASH)。

著录项

  • 公开/公告号CA3091774A1

    专利类型

  • 公开/公告日2019-08-29

    原文格式PDF

  • 申请/专利权人 EMULATE INC.;

    申请/专利号CA20193091774

  • 申请日2019-02-20

  • 分类号C12N5/071;G01N33/50;

  • 国家 CA

  • 入库时间 2022-08-21 11:58:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号